WASHINGTON — A senior Republican senator is wading into the debate over a controversial drug discount program with new legislation to require more transparency from hospitals that participate.
Sen. Chuck Grassley (R-Iowa) dropped legislation Thursday that takes aim at the so-called 340B program, which forces drug companies to give some public and nonprofit hospitals discounts on medicines. Through Medicare, the federal government then reimburses the facilities for the drugs at a higher rate.
About the Author Reprints
